{
  "docId": "019de074-6e40-7441-bfa0-d80627fc8d08",
  "docSlug": "25f3e01ba2b8d2af980e43ec911ed6e5",
  "documentTitle": "Absci | Investor Presentation Deck | 37 slides",
  "authorId": "absci",
  "authorName": "Absci",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 26,
  "pageCount": 37,
  "prevPage": 25,
  "nextPage": 27,
  "slideType": "solution",
  "function": "present_solution",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide illustrates the mechanism of incorporating non-standard amino acids into antibodies for ADC development.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-6e40-7441-bfa0-d80627fc8d08/26",
  "deckHref": "/decks/019de074-6e40-7441-bfa0-d80627fc8d08",
  "deckJsonHref": "/decks/019de074-6e40-7441-bfa0-d80627fc8d08.json",
  "deckAnchorHref": "/decks/019de074-6e40-7441-bfa0-d80627fc8d08#slide-26",
  "components": [
    {
      "bbox": {
        "h": 0.45,
        "w": 0.4,
        "x": 0.55,
        "y": 0.4
      },
      "kind": "image",
      "text": "EXPRESSION OF MAB IN BIONIC SOLUPRO™ CELL LINE (ADC PRECURSOR)",
      "attrs": null,
      "subkind": "infographic",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fc2e2d80-cd66-497c-ad43-fe90b12d6ead",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.45,
        "x": 0.05,
        "y": 0.55
      },
      "kind": "list",
      "text": "Bionic™ protein technology enables: Rapid assessment of payload location; Precise control over payload location; Uniform and homogenous Drug-Antibody-Ratio (DAR) for ADCs; Attachment of diverse chemical moieties for novel applications",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cee379e5-d3c6-4abe-88f5-6859fee2320e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.45,
        "x": 0.05,
        "y": 0.4
      },
      "kind": "paragraph",
      "text": "Absci is advancing a high-yielding SoluPro™ platform that enables selective site-specific nsAA incorporation into difficult-to-produce biologics",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c0491226-0f8b-4e95-8e39-68260ba7d58e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.8,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Bionic™ protein technology: Non-standard amino acid (nsAA) incorporation",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8449daf6-3da7-4e14-aa9a-f0aa0829b20a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Audience Definition",
      "slug": "audience-definition",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "ded40725-f69a-484c-aa85-52553dc6ddc6",
      "evidence": "Bionic protein technology enables",
      "confidence": 0.7
    },
    {
      "name": "Value Proposition Canvas",
      "slug": "value-proposition-canvas",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "80034469-3b2a-43a0-a7f3-b08ce0376168",
      "evidence": "Bionic protein technology enables",
      "confidence": 0.6
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}